POPOOLA, T. D., SEGUN, P. A., EKUADZI, E., DICKSON, R. A., AWOTONA, O. R., NAHAR, Lutfun, SARKER, S. D., FATOKUN, A. A. West African medicinal plants and their constituent compounds as treatments for viral infections, including SARS-CoV-2/COVID-19. DARU-Journal of Pharmaceutical Sciences. 2022, 30(1), 191-210. ISSN 1560-8115. E-ISSN 2008-2231
Objectives: The recent emergence of the COVID-19 pandemic (caused by SARS-CoV-2) and the experience of its unprecedented alarming toll on humanity have shone a fresh spotlight on the weakness of global preparedness for pandemics, significant health inequalities, and the fragility of healthcare systems in certain regions of the world. It is imperative to identify effective drug treatments for COVID-19. Therefore, the objective of this review is to present a unique and contextualised collection of antiviral natural plants or remedies from the West African sub-region as existing or potential treatments for viral infections, including COVID-19, with emphasis on their mechanisms of action. Evidence acquisition: Evidence was synthesised from the literature using appropriate keywords as search terms within scientific databases such as Scopus, PubMed, Web of Science and Google Scholar. Results: While some vaccines and small-molecule drugs are now available to combat COVID-19, access to these therapeutic entities in many countries is still quite limited. In addition, significant aspects of the symptomatology, pathophysiology and long-term prognosis of the infection yet remain unknown. The existing therapeutic armamentarium, therefore, requires significant expansion. There is evidence that natural products with antiviral effects have been used in successfully managing COVID-19 symptoms and could be developed as anti-COVID-19 agents which act through host- and virus-based molecular targets. Conclusion: Natural products could be successfully exploited for treating viral infections/diseases, including COVID-19. Strengthening natural products research capacity in developing countries is, therefore, a key strategy for reducing health inequalities, improving global health, and enhancing preparedness for future pandemics.
Institute of Experimental Botany of the Czech Academy of Sciences
Rozvojová 263
165 00 Praha 6 – Lysolaje
Česká republika

Reg. No.: 61389030
VAT number: CZ61389030
Data box: 4rgnvih
Tel.: +420 225 106 455
Fax.: +420 225 106 456
Email: ueb@ueb.cas.cz
Subscribe to Newsletter
I agree with the data processing terms
© Institute of Experimental Botany of the Czech Academy of Sciences